Article
Bridging Genetics and Precision Medicine in Parkinson’s Disease through GP2
2026-03-28
Abstract excerpt
In the Global Parkinson’s Genetics Program (GP2) we aim to advance precision medicine by integrating large-scale clinico-genetic data from diverse populations worldwide. We investigated potentially trial-eligible carriers of pathogenic and high-risk GBA1 and LRRK2 variants and conducted a global precision-medicine survey across GP2 sites. Among 65,509 individuals with Parkinson’s disease, we identified 9,019 (13...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e96991d0-e7d4-5195-a9e1-e089b220936f
- DOI
- 10.64898/2026.03.26.26349418
